PFE - Pfizer Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (-0.35%) NFLX (-0.17%) ETHUSD (%) UGAZ (-10.68%) LEVI (-1.6%) KAR (0.57%) IMRN (46.76%) GOOG (0.29%) FCG (-2.34%) FAST (1.96%) EBAY (-0.87%) DISCA (0.59%) DIS (-0.53%) CXW (-2.57%) CRZO (4.58%) CODX (6.39%) CMCSA (0.83%) CHWY (-0.85%) CEI (-11.03%) CDEV (-4.36%) CAPR (-3.7%) BTCUSD (%) BOOM (0.39%) BATUSD (%) AMZN (-0.55%)

Next Earnings Date : 7/30/2019

PFE - Pfizer

$42.85 0[0%]

15 mins delayed data

People also watch : LLY | AZN | JNJ | BMY | NVS | ABT

+Watchlist

10 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$42.85	Open
Volume		Market Cap	235.397B
Yield	0.033%	Last Dividend	$1.40

Day

52 Week

Should You Pick Up Novartis (NVS) Before...	07/16/19
Novartis AG (NVS) gained 1.1% so far in trading this week. Plus, the Swiss multinational pharmaceutical company has been on a tear since the end of Ap...

Pfizer (PFE) Gains As Market Dips: What ...	07/16/19
Pfizer (PFE) closed at $42.86 in the latest trading session, marking a +0.25% move from the prior day.

Top Research Reports for Berkshire Hatha...	07/16/19
Top Research Reports for Berkshire Hathaway, Pfizer & Danaher

How Financially Strong Is Pfizer Inc. (N...	07/16/19
Investors pursuing a solid, dependable stock investment can often be led to Pfizer Inc. (NYSE:PFE), a large-cap worth...

The opioid drugs scandal is depressingly...	07/15/19
US drug manufacturers and distributors are under the gun. Two decades into the opioid addiction epidemic that has killed more than 200,000 people, th...

Dow Jones Today: China, Earnings Anticip...	07/15/19
A somewhat slack economic report out of China, the world's second-largest economy, stood in the way of stocks notching big gains Monday.Source: Sh...

Biden healthcare plan would curb drug pr...	07/15/19
Former U.S. Vice President Joe Biden, the front-runner in the Democratic presidential race, unveiled a healthcare plan on Monday estimated to cost $75...

Drug Pricing Woes Linger on Repealing Dr...	07/12/19
Investors' skepticism runs rife as Trump drops the drug rebate proposal, pushing drugmakers to take center stage with regard to the controversial ...

AstraZeneca's Imfinzi Gains Orphan D...	07/12/19
The FDA assigns an orphan drug designation to AstraZeneca's (AZN) Imfinzi for the treatment of small cell lung cancer, the most aggressive type of...

Why one top exec at this $105 billion dr...	07/12/19
Ruud Dobber, AstraZeneca’s biopharmaceuticals president, weighs in on the Trump administration walking back one change it had been seeking in the drug...

Health Care stocks help lead Wall Street...	07/12/19
Yahoo Finance's Brian Sozzi, Alexis Christoforous, and Anjalee Khemlani break down what's driving the health care sector higher.

ANALYST RATINGS

3 analyst ratings (Last 6 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Strong Buy rating	06/04/19
and announces Price Target of $48.00

Buy rating	04/01/19
Bank of America maintains Buy rating and raises Price Target from $45.00 to $48.00

Strong Buy rating	01/31/19
Argus upgrades from Neutral to Outperform rating and announces Price Target of $55.00

EARNINGS

Date	2019-04-30 (BMO)	Est. (EPS/Rev.)	$0.75/ 13B
Actual (EPS/Rev.)	$0.85/ $13.12 B	EPS (TTM)	1.98

TRADERS TRACKING $PFE

Service Name	Trader	% Success
Write put options!	R. belegger	84.00 %	Subscribe
Exegesis	jonathan taylor	70.00 %	Subscribe
Dividend Play	Chirag Shah	69.00 %	Follow
Spread and Condor Play	Sankar	65.00 %	Subscribe
LavaPit	Steve Pitkin	58.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.